1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CYTOKINETICS INC
Cytokinetics Inc XNAS: CYTK
63.61 -0.17 (-0.27%)
558.8K
XNAS Volume

XNAS 21 Jan, 2026 11:08 AM (EST)

Watchlist

Portfolio

Alert

Cytokinetics Inc - CYTK - stock price prediction, stock price target, analyst ratings from 20 analysts

Cytokinetics Inc has a share price target of US$ 88, revenue growth forecast of 338.7%, and profit growth estimate of -30.3% for FY25, based on top 20 analyst calls.